Scientists discovered a smoke cessation therapy that involved bacterial enzyme. (Photo : Reuters)
Study shows that some smokers want to quit smoking but most of the time they fail to get through with it. Scientists from different universities in the United States has discovered a smoke cessation therapy that involves a bacterium called Pseudomonas putida that can help people to quit smoking without avoiding the use of the cigarette.
Pseudomonas putida, which looks like a little Pac-Man, is found in the soil from the tobacco fields were called nicA2 and it depends on nicotine as the source of carbon and nitrogen. From blood sample at a level corresponding to smoke one cigarette researchers added the nicA2 enzyme, the nicotine's life within blood was reduced from 2 to 3 hours to 9 to 15 minutes, Eurekalert reported.
According to the study published in JACS, bacterial enzyme can help people to prevent nicotine from reaching the brain. The scientists made a broad experimentation on bacterial enzyme and suggested that it can offer help to improve smoking cessation. The study of the scientists sees that it is possible to be viable drug candidate. The drug effect remains stable within a body temperature of 98 degrees for up to three weeks.
More than 30 years of study thrive before potential enzyme discovered, there is also a possibility that the number of smokers can fall in at least 80 to 90 percent. The scientist have tested that no toxic is produced while enzyme consumed nicotine. Scientists became optimistic that enzyme has the right properties to become successful therapeutic as they continue the study to develop the stability of the potential drug candidate to last longer to help stop smoking.
